01 1Curia
01 1TAPENTADOL HYDROCHLORIDE DRUG SUBSTANCE
01 1U.S.A
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2013-03-13
Pay. Date : 2012-11-02
DMF Number : 26490
Submission : 2012-09-27
Status : Active
Type : II
20
Curia Missouri Inc, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
They are recognized for Curia- A partner for the pharma and biotech industries to improve patient outcomes & quality of life.
One of their notable products is TAPENTADOL HYDROCHLORIDE DRUG SUBSTANCE, with a corresponding US DMF Number 26490.
Remarkably, this DMF maintains an Active status since its submission on September 27, 2012, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of March 13, 2013, and payment made on November 02, 2012, indicating their dedication to facilitating drug approvals, Categorized as Type II
